SlideShare a Scribd company logo
1 of 50
Download to read offline
The advent of
digital
microscopy
Yves Sucaet,
Wim Waelput,
Peter In’t Veld
14-11-2016 pag. 2
Financial disclosure
• Yves Sucaet and Wim Waelput are co-founders and
shareholders in Pathomation, an innovative company founded
in 2012. The company strives to offer the most
comprehensive software platform for digital pathology
possible. The focus is on integration, scalability, and user-
friendliness. Pathomation implements digital pathology in a
variety of use cases and scenarios.
14-11-2016 pag. 3
Prelude
• In October 2016, I was honored at Troy University as one of
its 2016 “alumni of the year” during the annual homecoming
activities.
• In the following week, I gave several guest lectures in various
departments across campus.
• This is the lecture as presented for the Business department
on Thursday, October 20, 2016.
14-11-2016 pag. 4
Topics for today
• How did I get here?
• Digital microscopy
• Digital pathology
• Companion diagnostics
PERSONAL BACKGROUND
14-11-2016 pag. 6
Who am I (education)?
• 1998-2000: Hogeschool Gent (BE)
– BS Computer Sciences
• 2001-2005: Troy State University (US)
– Exchange program
• Developed an interest in using ComS to help (molecular) biologists
– MS Biological Sciences
• Research in yeast genetics with Dr. Christi Magrath (NSF fellowship)
• 2005-2010: Iowa State University
– PhD Bioinformatics & Computational Biology
Education
14-11-2016 pag. 7
Who am I (professional)
Professional
• 2000-2001: Becton Dickinson
• 2010-2013: HistoGeneX
• Section head Data Management & Bioinformatics
• 2012-now: Pathomation
• Chief Technology Officer
• 2014-Q1 2017: VUB
• Digital Pathology Manager
• 2016-now: HistoGeneX
• Data scientist
WHAT IS DIGITAL MICROSCOPY?
14-11-2016 pag. 9
This is not it
14-11-2016 pag. 10
Digital microscopy on a budget
14-11-2016 pag. 11
Add a camera “port”
14-11-2016 pag. 12
Whole slide imaging (single slide)
14-11-2016 pag. 13
Hardware
14-11-2016 pag. 14
Whole slide imaging (clinical)
14-11-2016 pag. 15
Software
Very
large
image!
14-11-2016 pag. 16
How big are these images?
14-11-2016 pag. 17
Who does this?
14-11-2016 pag. 18
But the problem is that they don’t talk to each other!
14-11-2016 pag. 19
What’s the solution?
14-11-2016 pag. 20
Digital microscopy at the VUB
14-11-2016 pag. 21
What does the Pathomation software look like?
(DIGITAL) PATHOLOGY 101
14-11-2016 pag. 23
What does a pathologist do?
14-11-2016 pag. 24
Tools for pathologists
14-11-2016 pag. 25
Digital tools for pathologists
14-11-2016 pag. 26
Unique Selling Proposition and digital (r)evolution
14-11-2016 pag. 27
Valorization of a biobank
• Without digital histopathology: • With digital histopathology:
I’m looking for breast
tumor tissue
Does the sample
contain cancer cells
Is it in situ or
invasive?
Is it hormone-
responsive?
I’m looking for breast
tumor tissue
Does the sample
contain cancer cells
Is it in situ or
invasive?
Is it hormone-
responsive?
Sure; glad to help
Just trust us
Just trust us
We don’t have that
information
Sure; glad to help
Have a look at the HE
Have a look at the HE and
the immunostains
(p63 – calponine)
Have a look at the
immunostains and the fluo
data (FISH)
Fidelity increases, confident about
requests, investments pay off
14-11-2016 pag. 28
Market size
• Digital pathology is a $2 Billion market
– That’s actually small (it’s a niche market)
• GE is now dropping out of the race because of this!
• Medical imaging is a mature market
– Annual growth of about 5%
– Digital pathology: 14%
14-11-2016 pag. 29
M&A activity
THE ECONOMICS OF CANCER
14-11-2016 pag. 31
The cost of cancer drugs
14-11-2016 pag. 32
How do cancer drugs work?
• Rituximab, Rituxan:
– monoclonal Ab that attacks CD20+ B cells
– Leukemia, lymphoma
• Trastuzumab, Herceptin
– Interferes with Her2/Neu receptor
– Breast cancer
• Imatinib, Gleevec
– Tyrosine Kinase Inhibitor
– Chronic Myelogenous Leukemia (CML), Gastrointestinal
tumors (GITs)
• Everolimus, Afinitor
– HR+ (ER or PR), Her2 negative
– Breast cancer
14-11-2016 pag. 33
To prescribe or not to prescribe?
• Expensive drugs only work in a subset of patients
– Herceptin: 20-30% of early stage breast cancer
• Only to be used in HER2/Neu positive patients
• Cost: $4,659 / month
– Affinitor: 35% of patients respond
• Only to be used in Her2 negative, HR positive patients
• Cost: $8,701 / month
– Ibrance:
• Only to be used in ER positive, Her2 negative
• Also for metastatic cancer
• Cost: $10,677 / month
– Avastin + Erbitux
• Triple Negative Breast Cancer (TNBC)
• Cost: $5,551 + $11,862
14-11-2016 pag. 34
The need for personalized medicine
Cancer
therapy
Resection
Radio
therapy
Targeted
Immune
therapy
Research
Chemot
herapy
% patients responding: 25%
20-30% patients benefits
from ipilimumab
Epigenetics
Combinations
Lung cancer :
EGFR - gefitinib
ALK - crizotinib
14-11-2016 pag. 35
So what do you do?
• Companion diagnostics are tests that are administered to assess
what treatment is suited for a particular patient
– Can save lots of resources (time, money), and therefore
lives
– cDX is usually done on a (liquid) biopsy or resection
• Which means a pathologist is involved
– Allows clinician to take shortcuts!
• Sometimes a 3rd line treatment can be opted for directly as a 1st
line treatment
– Paves the way for personalized medicine
• Get the right drug to the right patient at the right time
• (at the right price for the patient and for society)
14-11-2016 pag. 36
How can digital microscopy help?
• In the future: Automatic assessment of stained slides
– Decision support systems
– Most importantly: help troubleshoot borderline
cases!
• Today: Training the pathologist for make the right assessment
– http://training.Pathomation.com
• Today: Facilitate discussion
– Tumor boards, multidisciplinary oncological consults
– Second opinions
14-11-2016 pag. 37
Decision support
Tumour
DOCTORS DON’T ALWAYS GET IT
RIGHT FROM THE FIRST VISIT
But even so…
14-11-2016 pag. 39
What would you do?
14-11-2016 pag. 40
The cost of change in a diagnosis (Mark Priebe)
14-11-2016 pag. 41
The cost of change in a diagnosis (Mark Priebe)
14-11-2016 pag. 42
Number of cancer cases, estimated total cost
• 1.6 million new cases are identified each year with a 5%
opportunity of improvement
– 80,000 cases annually
• Saving resources on 80,000 cases at $30,000 per case
– $2.4 Billion saving
14-11-2016 pag. 43
The stakes are high (loser)!
128B market cap / 83B market cap
14-11-2016 pag. 44
The stakes are high (winner)!
IN CLOSING
14-11-2016 pag. 46
This is a global market
14-11-2016 pag. 47
Potential customers, partners, and re-sellers
14-11-2016 pag. 48
Conclusions
• Digital pathology is ready for prime time
– Education and training,
– Research (including biobanking)
– Clinical research and drug development
• Business opportunities abound
– $2 B market size, $2.4B savings to be realized
– Hardware: scanners can still improve a LOT
– Software: needs to be more flexible, intuitive, user-
friendly (also programmer-friendly and MD-friendly)
– Consulting: team up with MDs!
14-11-2016 pag. 49
Learn more about digital pathology
14-11-2016 pag. 50
Continue the conversation
• Email: yves.sucaet@gmail.com
Thank you for inviting me!

More Related Content

Viewers also liked

4 hemostasis&thrombosis
4 hemostasis&thrombosis4 hemostasis&thrombosis
4 hemostasis&thrombosisPrasad CSBR
 
David Snead on The use of digital pathology in the primary diagnosis of histo...
David Snead on The use of digital pathology in the primary diagnosis of histo...David Snead on The use of digital pathology in the primary diagnosis of histo...
David Snead on The use of digital pathology in the primary diagnosis of histo...Cirdan
 
Icsh platelet counting reference method ajcp 2001
Icsh platelet counting reference method ajcp 2001Icsh platelet counting reference method ajcp 2001
Icsh platelet counting reference method ajcp 2001Raghuram Chary
 
Histopathology of malignant melanoma
Histopathology of malignant melanomaHistopathology of malignant melanoma
Histopathology of malignant melanomaRaghuram Chary
 
Neoplasia Robbin's path
Neoplasia Robbin's pathNeoplasia Robbin's path
Neoplasia Robbin's pathPrasad CSBR
 
Case stuies in Lymphomas
Case stuies in LymphomasCase stuies in Lymphomas
Case stuies in LymphomasPrasad CSBR
 

Viewers also liked (10)

Myelophthisic
MyelophthisicMyelophthisic
Myelophthisic
 
4 hemostasis&thrombosis
4 hemostasis&thrombosis4 hemostasis&thrombosis
4 hemostasis&thrombosis
 
Rbc disorders 8
Rbc disorders 8Rbc disorders 8
Rbc disorders 8
 
Govt debt 2012
Govt debt 2012Govt debt 2012
Govt debt 2012
 
David Snead on The use of digital pathology in the primary diagnosis of histo...
David Snead on The use of digital pathology in the primary diagnosis of histo...David Snead on The use of digital pathology in the primary diagnosis of histo...
David Snead on The use of digital pathology in the primary diagnosis of histo...
 
Icsh platelet counting reference method ajcp 2001
Icsh platelet counting reference method ajcp 2001Icsh platelet counting reference method ajcp 2001
Icsh platelet counting reference method ajcp 2001
 
Histopathology of malignant melanoma
Histopathology of malignant melanomaHistopathology of malignant melanoma
Histopathology of malignant melanoma
 
IVMS-CV-Pharmacology- Anti-hypertensive Agents
IVMS-CV-Pharmacology- Anti-hypertensive AgentsIVMS-CV-Pharmacology- Anti-hypertensive Agents
IVMS-CV-Pharmacology- Anti-hypertensive Agents
 
Neoplasia Robbin's path
Neoplasia Robbin's pathNeoplasia Robbin's path
Neoplasia Robbin's path
 
Case stuies in Lymphomas
Case stuies in LymphomasCase stuies in Lymphomas
Case stuies in Lymphomas
 

More from Yves Sucaet

Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyYves Sucaet
 
Explaining "digital" in digital pathology
Explaining "digital" in digital pathologyExplaining "digital" in digital pathology
Explaining "digital" in digital pathologyYves Sucaet
 
Do you want to build digital pathology software.pptx
Do you want to build digital pathology software.pptxDo you want to build digital pathology software.pptx
Do you want to build digital pathology software.pptxYves Sucaet
 
Pathomation PMA.UI framework examples
Pathomation PMA.UI framework examplesPathomation PMA.UI framework examples
Pathomation PMA.UI framework examplesYves Sucaet
 
Pathomation Pma.core 2 technology
Pathomation Pma.core 2 technologyPathomation Pma.core 2 technology
Pathomation Pma.core 2 technologyYves Sucaet
 
Pathomation platform description 2020 slide share edition
Pathomation platform description 2020   slide share editionPathomation platform description 2020   slide share edition
Pathomation platform description 2020 slide share editionYves Sucaet
 
Using a novel whole slide imaging software platform for an international mult...
Using a novel whole slide imaging software platform for an international mult...Using a novel whole slide imaging software platform for an international mult...
Using a novel whole slide imaging software platform for an international mult...Yves Sucaet
 
Pathomation product showcase
Pathomation product showcasePathomation product showcase
Pathomation product showcaseYves Sucaet
 
Digital Pathology Information Web Services (DPIWS): Convergence in Digital Pa...
Digital Pathology Information Web Services (DPIWS): Convergence in Digital Pa...Digital Pathology Information Web Services (DPIWS): Convergence in Digital Pa...
Digital Pathology Information Web Services (DPIWS): Convergence in Digital Pa...Yves Sucaet
 
Digital pathology and its importance as an omics data layer
Digital pathology and its importance as an omics data layerDigital pathology and its importance as an omics data layer
Digital pathology and its importance as an omics data layerYves Sucaet
 
A global integrative ecosystem for digital pathology: how can we get there?
A global integrative ecosystem for digital pathology: how can we get there?A global integrative ecosystem for digital pathology: how can we get there?
A global integrative ecosystem for digital pathology: how can we get there?Yves Sucaet
 
Whole slide imaging: beyond pathology (Pittsburgh Computational Pathology Lec...
Whole slide imaging: beyond pathology (Pittsburgh Computational Pathology Lec...Whole slide imaging: beyond pathology (Pittsburgh Computational Pathology Lec...
Whole slide imaging: beyond pathology (Pittsburgh Computational Pathology Lec...Yves Sucaet
 
The Troy lectures: The advent of digital microscopy (IT/ComS edition)
The Troy lectures: The advent of digital microscopy (IT/ComS edition)The Troy lectures: The advent of digital microscopy (IT/ComS edition)
The Troy lectures: The advent of digital microscopy (IT/ComS edition)Yves Sucaet
 
The Troy lectures: The advent of digital microscopy (biology edition)
The Troy lectures: The advent of digital microscopy (biology edition)The Troy lectures: The advent of digital microscopy (biology edition)
The Troy lectures: The advent of digital microscopy (biology edition)Yves Sucaet
 
Prepared to scale: experiences with building a department-wide digital pathol...
Prepared to scale: experiences with building a department-wide digital pathol...Prepared to scale: experiences with building a department-wide digital pathol...
Prepared to scale: experiences with building a department-wide digital pathol...Yves Sucaet
 
Using digital pathology to enhance a biobank portal
Using digital pathology to enhance a biobank portalUsing digital pathology to enhance a biobank portal
Using digital pathology to enhance a biobank portalYves Sucaet
 
Technical implementation details of a biobank portal enhanced with digital pa...
Technical implementation details of a biobank portal enhanced with digital pa...Technical implementation details of a biobank portal enhanced with digital pa...
Technical implementation details of a biobank portal enhanced with digital pa...Yves Sucaet
 
Reasons to engage in digital pathology in education
Reasons to engage in digital pathology in educationReasons to engage in digital pathology in education
Reasons to engage in digital pathology in educationYves Sucaet
 
Digital pathology landscape 2016
Digital pathology landscape 2016Digital pathology landscape 2016
Digital pathology landscape 2016Yves Sucaet
 

More from Yves Sucaet (19)

Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathology
 
Explaining "digital" in digital pathology
Explaining "digital" in digital pathologyExplaining "digital" in digital pathology
Explaining "digital" in digital pathology
 
Do you want to build digital pathology software.pptx
Do you want to build digital pathology software.pptxDo you want to build digital pathology software.pptx
Do you want to build digital pathology software.pptx
 
Pathomation PMA.UI framework examples
Pathomation PMA.UI framework examplesPathomation PMA.UI framework examples
Pathomation PMA.UI framework examples
 
Pathomation Pma.core 2 technology
Pathomation Pma.core 2 technologyPathomation Pma.core 2 technology
Pathomation Pma.core 2 technology
 
Pathomation platform description 2020 slide share edition
Pathomation platform description 2020   slide share editionPathomation platform description 2020   slide share edition
Pathomation platform description 2020 slide share edition
 
Using a novel whole slide imaging software platform for an international mult...
Using a novel whole slide imaging software platform for an international mult...Using a novel whole slide imaging software platform for an international mult...
Using a novel whole slide imaging software platform for an international mult...
 
Pathomation product showcase
Pathomation product showcasePathomation product showcase
Pathomation product showcase
 
Digital Pathology Information Web Services (DPIWS): Convergence in Digital Pa...
Digital Pathology Information Web Services (DPIWS): Convergence in Digital Pa...Digital Pathology Information Web Services (DPIWS): Convergence in Digital Pa...
Digital Pathology Information Web Services (DPIWS): Convergence in Digital Pa...
 
Digital pathology and its importance as an omics data layer
Digital pathology and its importance as an omics data layerDigital pathology and its importance as an omics data layer
Digital pathology and its importance as an omics data layer
 
A global integrative ecosystem for digital pathology: how can we get there?
A global integrative ecosystem for digital pathology: how can we get there?A global integrative ecosystem for digital pathology: how can we get there?
A global integrative ecosystem for digital pathology: how can we get there?
 
Whole slide imaging: beyond pathology (Pittsburgh Computational Pathology Lec...
Whole slide imaging: beyond pathology (Pittsburgh Computational Pathology Lec...Whole slide imaging: beyond pathology (Pittsburgh Computational Pathology Lec...
Whole slide imaging: beyond pathology (Pittsburgh Computational Pathology Lec...
 
The Troy lectures: The advent of digital microscopy (IT/ComS edition)
The Troy lectures: The advent of digital microscopy (IT/ComS edition)The Troy lectures: The advent of digital microscopy (IT/ComS edition)
The Troy lectures: The advent of digital microscopy (IT/ComS edition)
 
The Troy lectures: The advent of digital microscopy (biology edition)
The Troy lectures: The advent of digital microscopy (biology edition)The Troy lectures: The advent of digital microscopy (biology edition)
The Troy lectures: The advent of digital microscopy (biology edition)
 
Prepared to scale: experiences with building a department-wide digital pathol...
Prepared to scale: experiences with building a department-wide digital pathol...Prepared to scale: experiences with building a department-wide digital pathol...
Prepared to scale: experiences with building a department-wide digital pathol...
 
Using digital pathology to enhance a biobank portal
Using digital pathology to enhance a biobank portalUsing digital pathology to enhance a biobank portal
Using digital pathology to enhance a biobank portal
 
Technical implementation details of a biobank portal enhanced with digital pa...
Technical implementation details of a biobank portal enhanced with digital pa...Technical implementation details of a biobank portal enhanced with digital pa...
Technical implementation details of a biobank portal enhanced with digital pa...
 
Reasons to engage in digital pathology in education
Reasons to engage in digital pathology in educationReasons to engage in digital pathology in education
Reasons to engage in digital pathology in education
 
Digital pathology landscape 2016
Digital pathology landscape 2016Digital pathology landscape 2016
Digital pathology landscape 2016
 

Recently uploaded

Young Woman Entrepreneur - Kaviya Cherian
Young Woman Entrepreneur - Kaviya CherianYoung Woman Entrepreneur - Kaviya Cherian
Young Woman Entrepreneur - Kaviya CherianCDEEPANVITA
 
14 march 2024-capital-markets-update eni.pdf
14 march 2024-capital-markets-update eni.pdf14 march 2024-capital-markets-update eni.pdf
14 march 2024-capital-markets-update eni.pdfEni
 
Meet Raj Shamani: A Trailblazing Entrepreneur
Meet Raj Shamani: A Trailblazing EntrepreneurMeet Raj Shamani: A Trailblazing Entrepreneur
Meet Raj Shamani: A Trailblazing Entrepreneurramya202104
 
The Vietnam Believer_Newsletter_Vol.001_Mar12 2024
The Vietnam Believer_Newsletter_Vol.001_Mar12 2024The Vietnam Believer_Newsletter_Vol.001_Mar12 2024
The Vietnam Believer_Newsletter_Vol.001_Mar12 2024believeminhh
 
Shravan Kumaran and sanjay kumaran.pdf..
Shravan Kumaran and sanjay kumaran.pdf..Shravan Kumaran and sanjay kumaran.pdf..
Shravan Kumaran and sanjay kumaran.pdf..ranjithapriya2
 
Importance of Commercial Vehicle Insurance.pptx
Importance of Commercial Vehicle Insurance.pptxImportance of Commercial Vehicle Insurance.pptx
Importance of Commercial Vehicle Insurance.pptxBonano Insurance
 
10 Tips for Great Teams CSUN Conference 2024
10 Tips for Great Teams CSUN Conference 202410 Tips for Great Teams CSUN Conference 2024
10 Tips for Great Teams CSUN Conference 2024Nate Evans
 
HOW TO START EARNING WITH AFFILIATE MARKETING
HOW TO START EARNING WITH AFFILIATE MARKETINGHOW TO START EARNING WITH AFFILIATE MARKETING
HOW TO START EARNING WITH AFFILIATE MARKETINGNATHAN SPEAKS
 
Reframing Requirements: A Strategic Approach to Requirement Definition, with ...
Reframing Requirements: A Strategic Approach to Requirement Definition, with ...Reframing Requirements: A Strategic Approach to Requirement Definition, with ...
Reframing Requirements: A Strategic Approach to Requirement Definition, with ...Jake Truemper
 
Presented by Sabri international .......
Presented by Sabri international .......Presented by Sabri international .......
Presented by Sabri international .......SABRI INTERNATIONAL
 
The Smart Bridge Interview now Veranda Learning
The Smart Bridge Interview now Veranda LearningThe Smart Bridge Interview now Veranda Learning
The Smart Bridge Interview now Veranda LearningNaval Singh
 
CXO 2.0 Conference (Event Information Deck | Dec'24-Mar'25)
CXO 2.0 Conference (Event Information Deck | Dec'24-Mar'25)CXO 2.0 Conference (Event Information Deck | Dec'24-Mar'25)
CXO 2.0 Conference (Event Information Deck | Dec'24-Mar'25)CXO 2.0 Conference
 
L-1 VISA Business (Plan Sample) - Plan Writers
L-1 VISA Business (Plan Sample) - Plan WritersL-1 VISA Business (Plan Sample) - Plan Writers
L-1 VISA Business (Plan Sample) - Plan WritersPlan Writers
 
Pitch Deck Teardown: SuperScale's $5.4M Series A deck
Pitch Deck Teardown: SuperScale's $5.4M Series A deckPitch Deck Teardown: SuperScale's $5.4M Series A deck
Pitch Deck Teardown: SuperScale's $5.4M Series A deckHajeJanKamps
 
Olympus 38DL Plus Ultrasonic Thickness Gauge
Olympus 38DL Plus Ultrasonic Thickness GaugeOlympus 38DL Plus Ultrasonic Thickness Gauge
Olympus 38DL Plus Ultrasonic Thickness GaugeStephenKim86
 
Project Work on Consumer Behavior in Fast Food Restaurants. Their behavior to...
Project Work on Consumer Behavior in Fast Food Restaurants. Their behavior to...Project Work on Consumer Behavior in Fast Food Restaurants. Their behavior to...
Project Work on Consumer Behavior in Fast Food Restaurants. Their behavior to...BilalAhmed717
 
Bus Eth ch3 ppt.ppt business ethics and corporate social responsibilities ppt
Bus Eth ch3 ppt.ppt business ethics and corporate social responsibilities pptBus Eth ch3 ppt.ppt business ethics and corporate social responsibilities ppt
Bus Eth ch3 ppt.ppt business ethics and corporate social responsibilities pptendeworku
 
Digital Marketing Training Program skills s
Digital Marketing Training Program skills sDigital Marketing Training Program skills s
Digital Marketing Training Program skills sgodxzyrox
 

Recently uploaded (20)

Young Woman Entrepreneur - Kaviya Cherian
Young Woman Entrepreneur - Kaviya CherianYoung Woman Entrepreneur - Kaviya Cherian
Young Woman Entrepreneur - Kaviya Cherian
 
14 march 2024-capital-markets-update eni.pdf
14 march 2024-capital-markets-update eni.pdf14 march 2024-capital-markets-update eni.pdf
14 march 2024-capital-markets-update eni.pdf
 
Meet Raj Shamani: A Trailblazing Entrepreneur
Meet Raj Shamani: A Trailblazing EntrepreneurMeet Raj Shamani: A Trailblazing Entrepreneur
Meet Raj Shamani: A Trailblazing Entrepreneur
 
WAM Corporate Presentation Mar 12 2024.pdf
WAM Corporate Presentation Mar 12 2024.pdfWAM Corporate Presentation Mar 12 2024.pdf
WAM Corporate Presentation Mar 12 2024.pdf
 
The Vietnam Believer_Newsletter_Vol.001_Mar12 2024
The Vietnam Believer_Newsletter_Vol.001_Mar12 2024The Vietnam Believer_Newsletter_Vol.001_Mar12 2024
The Vietnam Believer_Newsletter_Vol.001_Mar12 2024
 
Shravan Kumaran and sanjay kumaran.pdf..
Shravan Kumaran and sanjay kumaran.pdf..Shravan Kumaran and sanjay kumaran.pdf..
Shravan Kumaran and sanjay kumaran.pdf..
 
Importance of Commercial Vehicle Insurance.pptx
Importance of Commercial Vehicle Insurance.pptxImportance of Commercial Vehicle Insurance.pptx
Importance of Commercial Vehicle Insurance.pptx
 
10 Tips for Great Teams CSUN Conference 2024
10 Tips for Great Teams CSUN Conference 202410 Tips for Great Teams CSUN Conference 2024
10 Tips for Great Teams CSUN Conference 2024
 
HOW TO START EARNING WITH AFFILIATE MARKETING
HOW TO START EARNING WITH AFFILIATE MARKETINGHOW TO START EARNING WITH AFFILIATE MARKETING
HOW TO START EARNING WITH AFFILIATE MARKETING
 
Reframing Requirements: A Strategic Approach to Requirement Definition, with ...
Reframing Requirements: A Strategic Approach to Requirement Definition, with ...Reframing Requirements: A Strategic Approach to Requirement Definition, with ...
Reframing Requirements: A Strategic Approach to Requirement Definition, with ...
 
Presented by Sabri international .......
Presented by Sabri international .......Presented by Sabri international .......
Presented by Sabri international .......
 
The Smart Bridge Interview now Veranda Learning
The Smart Bridge Interview now Veranda LearningThe Smart Bridge Interview now Veranda Learning
The Smart Bridge Interview now Veranda Learning
 
CXO 2.0 Conference (Event Information Deck | Dec'24-Mar'25)
CXO 2.0 Conference (Event Information Deck | Dec'24-Mar'25)CXO 2.0 Conference (Event Information Deck | Dec'24-Mar'25)
CXO 2.0 Conference (Event Information Deck | Dec'24-Mar'25)
 
L-1 VISA Business (Plan Sample) - Plan Writers
L-1 VISA Business (Plan Sample) - Plan WritersL-1 VISA Business (Plan Sample) - Plan Writers
L-1 VISA Business (Plan Sample) - Plan Writers
 
Pitch Deck Teardown: SuperScale's $5.4M Series A deck
Pitch Deck Teardown: SuperScale's $5.4M Series A deckPitch Deck Teardown: SuperScale's $5.4M Series A deck
Pitch Deck Teardown: SuperScale's $5.4M Series A deck
 
Olympus 38DL Plus Ultrasonic Thickness Gauge
Olympus 38DL Plus Ultrasonic Thickness GaugeOlympus 38DL Plus Ultrasonic Thickness Gauge
Olympus 38DL Plus Ultrasonic Thickness Gauge
 
Project Work on Consumer Behavior in Fast Food Restaurants. Their behavior to...
Project Work on Consumer Behavior in Fast Food Restaurants. Their behavior to...Project Work on Consumer Behavior in Fast Food Restaurants. Their behavior to...
Project Work on Consumer Behavior in Fast Food Restaurants. Their behavior to...
 
WAM Corporate Presentation Mar 12 2024_Video.pdf
WAM Corporate Presentation Mar 12 2024_Video.pdfWAM Corporate Presentation Mar 12 2024_Video.pdf
WAM Corporate Presentation Mar 12 2024_Video.pdf
 
Bus Eth ch3 ppt.ppt business ethics and corporate social responsibilities ppt
Bus Eth ch3 ppt.ppt business ethics and corporate social responsibilities pptBus Eth ch3 ppt.ppt business ethics and corporate social responsibilities ppt
Bus Eth ch3 ppt.ppt business ethics and corporate social responsibilities ppt
 
Digital Marketing Training Program skills s
Digital Marketing Training Program skills sDigital Marketing Training Program skills s
Digital Marketing Training Program skills s
 

The Troy lectures: The advent of digital microscopy (business school edition)

  • 1. The advent of digital microscopy Yves Sucaet, Wim Waelput, Peter In’t Veld
  • 2. 14-11-2016 pag. 2 Financial disclosure • Yves Sucaet and Wim Waelput are co-founders and shareholders in Pathomation, an innovative company founded in 2012. The company strives to offer the most comprehensive software platform for digital pathology possible. The focus is on integration, scalability, and user- friendliness. Pathomation implements digital pathology in a variety of use cases and scenarios.
  • 3. 14-11-2016 pag. 3 Prelude • In October 2016, I was honored at Troy University as one of its 2016 “alumni of the year” during the annual homecoming activities. • In the following week, I gave several guest lectures in various departments across campus. • This is the lecture as presented for the Business department on Thursday, October 20, 2016.
  • 4. 14-11-2016 pag. 4 Topics for today • How did I get here? • Digital microscopy • Digital pathology • Companion diagnostics
  • 6. 14-11-2016 pag. 6 Who am I (education)? • 1998-2000: Hogeschool Gent (BE) – BS Computer Sciences • 2001-2005: Troy State University (US) – Exchange program • Developed an interest in using ComS to help (molecular) biologists – MS Biological Sciences • Research in yeast genetics with Dr. Christi Magrath (NSF fellowship) • 2005-2010: Iowa State University – PhD Bioinformatics & Computational Biology Education
  • 7. 14-11-2016 pag. 7 Who am I (professional) Professional • 2000-2001: Becton Dickinson • 2010-2013: HistoGeneX • Section head Data Management & Bioinformatics • 2012-now: Pathomation • Chief Technology Officer • 2014-Q1 2017: VUB • Digital Pathology Manager • 2016-now: HistoGeneX • Data scientist
  • 8. WHAT IS DIGITAL MICROSCOPY?
  • 10. 14-11-2016 pag. 10 Digital microscopy on a budget
  • 11. 14-11-2016 pag. 11 Add a camera “port”
  • 12. 14-11-2016 pag. 12 Whole slide imaging (single slide)
  • 14. 14-11-2016 pag. 14 Whole slide imaging (clinical)
  • 16. 14-11-2016 pag. 16 How big are these images?
  • 18. 14-11-2016 pag. 18 But the problem is that they don’t talk to each other!
  • 20. 14-11-2016 pag. 20 Digital microscopy at the VUB
  • 21. 14-11-2016 pag. 21 What does the Pathomation software look like?
  • 23. 14-11-2016 pag. 23 What does a pathologist do?
  • 24. 14-11-2016 pag. 24 Tools for pathologists
  • 25. 14-11-2016 pag. 25 Digital tools for pathologists
  • 26. 14-11-2016 pag. 26 Unique Selling Proposition and digital (r)evolution
  • 27. 14-11-2016 pag. 27 Valorization of a biobank • Without digital histopathology: • With digital histopathology: I’m looking for breast tumor tissue Does the sample contain cancer cells Is it in situ or invasive? Is it hormone- responsive? I’m looking for breast tumor tissue Does the sample contain cancer cells Is it in situ or invasive? Is it hormone- responsive? Sure; glad to help Just trust us Just trust us We don’t have that information Sure; glad to help Have a look at the HE Have a look at the HE and the immunostains (p63 – calponine) Have a look at the immunostains and the fluo data (FISH) Fidelity increases, confident about requests, investments pay off
  • 28. 14-11-2016 pag. 28 Market size • Digital pathology is a $2 Billion market – That’s actually small (it’s a niche market) • GE is now dropping out of the race because of this! • Medical imaging is a mature market – Annual growth of about 5% – Digital pathology: 14%
  • 31. 14-11-2016 pag. 31 The cost of cancer drugs
  • 32. 14-11-2016 pag. 32 How do cancer drugs work? • Rituximab, Rituxan: – monoclonal Ab that attacks CD20+ B cells – Leukemia, lymphoma • Trastuzumab, Herceptin – Interferes with Her2/Neu receptor – Breast cancer • Imatinib, Gleevec – Tyrosine Kinase Inhibitor – Chronic Myelogenous Leukemia (CML), Gastrointestinal tumors (GITs) • Everolimus, Afinitor – HR+ (ER or PR), Her2 negative – Breast cancer
  • 33. 14-11-2016 pag. 33 To prescribe or not to prescribe? • Expensive drugs only work in a subset of patients – Herceptin: 20-30% of early stage breast cancer • Only to be used in HER2/Neu positive patients • Cost: $4,659 / month – Affinitor: 35% of patients respond • Only to be used in Her2 negative, HR positive patients • Cost: $8,701 / month – Ibrance: • Only to be used in ER positive, Her2 negative • Also for metastatic cancer • Cost: $10,677 / month – Avastin + Erbitux • Triple Negative Breast Cancer (TNBC) • Cost: $5,551 + $11,862
  • 34. 14-11-2016 pag. 34 The need for personalized medicine Cancer therapy Resection Radio therapy Targeted Immune therapy Research Chemot herapy % patients responding: 25% 20-30% patients benefits from ipilimumab Epigenetics Combinations Lung cancer : EGFR - gefitinib ALK - crizotinib
  • 35. 14-11-2016 pag. 35 So what do you do? • Companion diagnostics are tests that are administered to assess what treatment is suited for a particular patient – Can save lots of resources (time, money), and therefore lives – cDX is usually done on a (liquid) biopsy or resection • Which means a pathologist is involved – Allows clinician to take shortcuts! • Sometimes a 3rd line treatment can be opted for directly as a 1st line treatment – Paves the way for personalized medicine • Get the right drug to the right patient at the right time • (at the right price for the patient and for society)
  • 36. 14-11-2016 pag. 36 How can digital microscopy help? • In the future: Automatic assessment of stained slides – Decision support systems – Most importantly: help troubleshoot borderline cases! • Today: Training the pathologist for make the right assessment – http://training.Pathomation.com • Today: Facilitate discussion – Tumor boards, multidisciplinary oncological consults – Second opinions
  • 37. 14-11-2016 pag. 37 Decision support Tumour
  • 38. DOCTORS DON’T ALWAYS GET IT RIGHT FROM THE FIRST VISIT But even so…
  • 39. 14-11-2016 pag. 39 What would you do?
  • 40. 14-11-2016 pag. 40 The cost of change in a diagnosis (Mark Priebe)
  • 41. 14-11-2016 pag. 41 The cost of change in a diagnosis (Mark Priebe)
  • 42. 14-11-2016 pag. 42 Number of cancer cases, estimated total cost • 1.6 million new cases are identified each year with a 5% opportunity of improvement – 80,000 cases annually • Saving resources on 80,000 cases at $30,000 per case – $2.4 Billion saving
  • 43. 14-11-2016 pag. 43 The stakes are high (loser)! 128B market cap / 83B market cap
  • 44. 14-11-2016 pag. 44 The stakes are high (winner)!
  • 46. 14-11-2016 pag. 46 This is a global market
  • 47. 14-11-2016 pag. 47 Potential customers, partners, and re-sellers
  • 48. 14-11-2016 pag. 48 Conclusions • Digital pathology is ready for prime time – Education and training, – Research (including biobanking) – Clinical research and drug development • Business opportunities abound – $2 B market size, $2.4B savings to be realized – Hardware: scanners can still improve a LOT – Software: needs to be more flexible, intuitive, user- friendly (also programmer-friendly and MD-friendly) – Consulting: team up with MDs!
  • 49. 14-11-2016 pag. 49 Learn more about digital pathology
  • 50. 14-11-2016 pag. 50 Continue the conversation • Email: yves.sucaet@gmail.com Thank you for inviting me!